Source: WVTM, by Shannon Delcambre (September 16, 2026). AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- Alabama awarded more than $262,000 to its Department of Forensic Sciences for drug-investigation and forensic-service equipment.
- The grant will fund a random access biochip analyzer that performs multiple drug screenings from one patient sample.
- The announcement does not name the analyzer manufacturer, test menu, deployment date, or allocation of funds between purchases.
Alabama has awarded more than $262,000 to the Alabama Department of Forensic Sciences to upgrade equipment used in drug investigations and other forensic services. The funding will purchase a random access biochip technology analyzer, a device designed to run multiple drug screenings from one patient sample. That capability could support investigations involving opioids and other synthetic drugs, substances that can require laboratories to test for many compounds quickly. The grant also covers new morgue equipment. Gov. Kay Ivey's office announced the award as part of a federal program that supports upgrades to forensic science and coroner services in states and cities. A biochip analyzer is central to the investment because it combines several tests on a small platform rather than requiring a separate setup for every screen. The announcement does not identify the analyzer's manufacturer, its specific test menu, or when the department will begin using it. Still, the purchase signals an effort to expand Alabama's forensic capacity for drug-related cases while also updating tools used after death investigations.
A Grant for Forensic Capacity
The award exceeds $262,000 and goes to the Alabama Department of Forensic Sciences, the state agency that provides forensic services for investigations. The governor's office said the money will fund equipment for drug case work as well as broader forensic operations.
The funding comes through a federal program focused on improving forensic science and coroner services in state and local jurisdictions. Alongside the drug-testing system, Alabama plans to acquire new equipment for its morgue operations.
What a Random Access Biochip Analyzer Does
A biochip is a small testing surface that can carry many chemical assays, or individual laboratory tests, at once. Think of it like a compact panel of locks, where each lock responds only to a particular key. In drug testing, each assay is designed to recognize a target drug, drug class, or related chemical marker.
The announced instrument is described as a random access biochip technology analyzer. “Random access” generally means the system can handle different requested tests without arranging every sample into one fixed testing sequence. That flexibility is useful when laboratories need to screen samples for different combinations of substances.
The analyzer can quickly perform multiple drug screens from a single patient sample, according to the governor's office. Instead of dividing a sample across numerous separate procedures, a multipanel approach can use one specimen to produce several screening results. Screening identifies samples that may warrant further forensic analysis, rather than independently establishing every detail of a case.
Focus on Opioids and Synthetic Drugs
Alabama will use the grant-supported equipment to assist cases involving opioids and other synthetic drugs. Synthetic drugs are compounds made or chemically modified in laboratories, and they can present a moving target for forensic testing when new substances or variants appear.
Forensic laboratories need tools that can process evidence reliably while managing a range of possible drug exposures. The planned analyzer's ability to run multiple screenings from one sample is the specific platform feature cited in the award announcement.
Morgue Equipment Is Also Included
The grant is not limited to the biochip analyzer. The Alabama Department of Forensic Sciences will also use the funds to purchase new morgue equipment, supporting the agency's work in forensic and coroner services.
The announcement does not specify which morgue instruments Alabama will buy or how the funds will be divided between the drug-testing analyzer and morgue upgrades. It also does not state whether the equipment will be installed at one facility or distributed across multiple sites.
Why This Matters
Drug investigations often depend on laboratories being able to assess a sample for more than one possible substance. A biochip-based analyzer is designed for that kind of multiplexed screening, meaning multiple assays can be carried out on a single sample. For a forensic agency, that is a practical platform investment rather than simply a purchase of routine lab supplies.
The award also connects drug testing with the broader infrastructure of death investigation. By pairing the analyzer with morgue equipment, Alabama is directing federal support toward both analytical testing and the physical operations that underpin forensic services.
The next important details will be the analyzer selected, the drug panels it can run, and how the Alabama Department of Forensic Sciences integrates it into its casework. Those choices will determine the specific role the new biochip platform plays in the state's response to opioid and synthetic-drug investigations.